Molecular imaging probe development: a chemistry perspective.
Molecular imaging probe development: a chemistry perspective.
复制标题
DOI：
--
复制
发表时间：
2012-07
影响因子：
2.5
通讯作者：
Donald D. Nolting;Michael L. Nickels;Ning Guo;W. Pham
中科院分区：
文献类型：
--
作者：
Donald D. Nolting;Michael L. Nickels;Ning Guo;W. Pham
Molecular imaging is an attractive modality that has been widely employed in many aspects of biomedical research; especially those aimed at the early detection of diseases such as cancer, inflammation and neurodegenerative disorders. The field emerged in response to a new research paradigm in healthcare that seeks to integrate detection capabilities for the prediction and prevention of diseases. This approach made a distinct impact in biomedical research as it enabled researchers to leverage the capabilities of molecular imaging probes to visualize a targeted molecular event non-invasively, repeatedly and continuously in a living system. In addition, since such probes are inherently compact, robust, and amenable to high-throughput production, these probes could potentially facilitate screening of preclinical drug discovery, therapeutic assessment and validation of disease biomarkers. They could also be useful in drug discovery and safety evaluations. In this review, major trends in the chemical synthesis and development of positron emission tomography (PET), optical and magnetic resonance imaging (MRI) probes are discussed.
